The increasing prevalence of atrial fibrillation among hemodialysis patients

Journal of the American Society of Nephrology

Volumn 22, Issue 2, 2011, Pages 349-357

  Winkelmayer, Wolfgang C ^a,b   Patrick, Amanda R ^a   Liu, Jun ^a   Brookhart, M Alan ^a,c   Setoguchi, Soko ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; CARDIOVASCULAR RISK; CAUCASIAN; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENDER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEGRO; NEOPLASM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RACE; UNITED STATES;

EID: 79551698394     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010050459     Document Type: Article

References (37)

1. U.S. Renal Data System: USRDS 2009 Annual Data Report: Volume Three: Reference Tables on End-Stage Renal Disease, Section D: Treatment Modalities, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2009, p 510
2. Herzog CA, Ma JZ, Collins AJ: Long-term outcome of dialysis patients in the United States hospitalized with atrial fibrillation [Abstract]. J Am Soc Nephrol 13: 433A, 2002
3. U.S. Renal Data System: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Chapter 9: Cardiovascular Special Studies, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2005, pp 173-184
4. Abe S, Yoshizawa M, Nakanishi N, Yazawa T, Yokota K, Honda M, Sloman G: Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 131: 1137-1144, 1996
5. Fabbian F, Catalano C, Lambertini D, Tarroni G, Bordin V, Squerzanti R, Gilli P, Di Landro D, Cavagna R: Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol 54: 234-239, 2000
6. Vazquez E, Sanchez-Perales C, Borrego F, Garcia-Cortes MJ, Lozano C, Guzman M, Gil JM, Borrego MJ, Perez V: Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 140: 886-890, 2000
7. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, Stella A, Bonforte G, DeVecchi A, DeCristofaro V, Buccianti G, Vincenti A: Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46: 897-902, 2005
8. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: e257-e354, 2006
9. Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA: Atrial fibrillation and stroke in the general Medicare population: A 10-year perspective (1992 to 2002). Stroke 37: 1969-1974, 2006
10. Ruo B, Capra AM, Jensvold NG, Go AS: Racial variation in the prevalence of atrial fibrillation among patients with heart failure: The Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol 43: 429-435, 2004 (Pubitemid 38167704)
11. Vazquez E, Sanchez-Perales C, Garcia-Garcia F, Castellano P, Garcia-Cortes MJ, Liebana A, Lozano C: Atrial fibrillation in incident dialysis patients. Kidney Int 76: 324-330, 2009
12. Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR: Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 158: 111-117, 2009
13. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM: Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96: 2455-2461, 1997
14. McDonald AJ, Pelletier AJ, Ellinor PT, Camargo CA Jr: Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med 51: 58-65, 2008
15. Khairallah F, Ezzedine R, Ganz LI, London B, Saba S: Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001. Am J Cardiol 94: 500-504, 2004
16. Bleyer AJ, Tell GS, Evans GW, Ettinger WH Jr, Burkart JM: Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. Am J Kidney Dis 28: 72-81, 1996
17. Mesler DE, McCarthy EP, Byrne-Logan S, Ash AS, Moskowitz MA: Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment? Am J Med 106: 300-306, 1999
18. Pei YP, Greenwood CM, Chery AL, Wu GG: Racial differences in survival of patients on dialysis. Kidney Int 58: 1293-1299, 2000
19. Robinson BM, Joffe MM, Pisoni RL, Port FK, Feldman HI: Revisiting survival differences by race and ethnicity among hemodialysis patients: The Dialysis Outcomes and Practice Patterns Study. J Am Soc Nephrol 17: 2910-2918, 2006
20. Agodoa L, Eggers P: Racial and ethnic disparities in end-stage kidney failure - Survival paradoxes in African-Americans. Semin Dial 20: 577-585, 2007
21. Trivedi H, Xiang Q, Klein JP: Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrol Dial Transplant 24: 258-266, 2009
22. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004
23. Smith GL, Shlipak MG, Havranek EP, Masoudi FA, McClellan WM, Foody JM, Rathore SS, Krumholz HM: Race and renal impairment in heart failure: Mortality in blacks versus whites. Circulation 111: 1270-1277, 2005
24. Bellasi A, Veledar E, Ferramosca E, Ratti C, Block G, Raggi P: Markers of vascular disease do not differ in black and white hemodialysis patients despite a different risk profile. Atherosclerosis 197: 242-249, 2008
25. Reinecke H, Brand E, Mesters R, Schabitz WR, Fisher M, Pavenstadt H, Breithardt G: Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20: 705-711, 2009
26. Chan KE, Lazarus JM, Thadhani R, Hakim RM: Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 20: 2223-2233, 2009
27. Wizemann V, Tong L, Satayathum S, Disney A, Akiba T, Fissell RB, Kerr PG, Young EW, Robinson BM: Atrial fibrillation in hemodialysis patients: Clinical features and associations with anticoagulant therapy. Kidney Int 77: 1098-1106, 2010
28. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB: Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J 131: 790-795, 1996
29. Tsang TS, Petty GW, Barnes ME, O'Fallon WM, Bailey KR, Wiebers DO, Sicks JD, Christianson TJ, Seward JB, Gersh BJ: The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: Changes over three decades. J Am Coll Cardiol 42: 93-100, 2003
30. U.S. Renal Data System: Researcher's Guide to the USRDS Database, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005
31. Yan Y, Birman-Deych E, Radford MJ, Nilasena DS, Gage BF: Comorbidity indices to predict mortality from Medicare data: Results from the national registry of atrial fibrillation. Med Care 43: 1073-1077, 2005
32. Choudhry NK, Soumerai SB, Normand SL, Ross-Degnan D, Laupacis A, Anderson GM: Warfarin prescribing in atrial fibrillation: The impact of physician, patient, and hospital characteristics. Am J Med 119: 607-615, 2006
33. Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB: Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: Matched pair analysis. BMJ 332: 141-145, 2006
34. Lentine KL, Schnitzler MA, Abbott KC, Li L, Xiao H, Burroughs TE, Takemoto SK, Willoughby LM, Gavard JA, Brennan DC: Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol 1: 288-296, 2006
35. Kokotailo RA, Hill MD: Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 36: 1776-1781, 2005
36. Frost L, Vestergaard P: Caffeine and risk of atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am J Clin Nutr 81: 578-582, 2005
37. Zou G: A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159: 702-706, 2004